Manufacturer record
Nuvista Pharmaceuticals Pvt.Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Nuvista Pharmaceuticals Pvt.Ltd (Telangana) were declared Not of Standard Quality between October 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Nuvista Pharmaceuticals Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Closantel& Ivermectin Oral Liquid Vet | NAP-25068Mfg 2025-11 · Exp 2027-10 | Identificatio n and Assay of IvermectinAssay | SDTL,Andhra Pradesh, VijayawadaState lab | Jun 2026 |
| Ferrous Ascorbate and Folic Acid Tablet | NAC25006Mfg 2025-11 · Exp 2027-10 | 1. Assay for Elemental Iron Does not complies as per IP 2022. 2. In the compostion the label should be mentioned as Ferrous Ascorbate and Folic Acid IP. But the label is mentioned as only Ferrous Ascorbate and Folic Acid. The letters IP is not mentioned on the strip. 3. In the compostion it should be mentioned as Ferrous Ascrobate equivalent to Elemental Iron, but it is labelled as only Ferrous Ascorbate 100 mg.Assay | State Lab, DCL, TelanganaState lab | Apr 2026 |
| Amlodipine Besylate and Atenolol Tablets | NPD-6637Mfg 2024-01 · Exp 2025-12 | MISBRANDED The product label should be mentioned as Amlodipine besylate and Atenolol tablets IP. But the label is mentioned as Amlodipine besylate and Atenolol tablets only.Misbranded | DCL TelanganaState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.